07 Jan 2001

Remergil® 30 (Remergil® 30 mg/-45 mg Filmtabletten) - Deutschland

Updated: 07 Jan 2001

Remergil® 30 mg | -45 mg Filmtabletten; -6 mg | 2 ml | -15 mg | 5 ml Konzentrat

Depressive Erkrankungen.

Remergil® 30 Description, Presentation and Dosage

Remergil® 30 Description

Remergil® 30 Drug Class Description


Remergil® 30 Drug Description

1 Filmtbl. enth.: Mirtazapin 30 mg/45 mg.

Remergil® 30 Generic Name

Remergil® 30 mg/-45 mg Filmtabletten

Remergil® 30 Presentation

Remergil® 30 Presentation

Remergil® 30 mg/-45 mg Filmtabletten; -6 mg/2 ml/-15 mg/5 ml Konzentrat

Remergil® 30 Manufacturer


Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.


IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Remergil® 30 Dosage

Remergil® 30 Adult Dosage

Lactose 1H2O, Maisstärke, Hydroxypropylcellulose, Hochdisperses Siliciumdioxid, Magnesiumstearat, Poly(O-2-hydroxypropyl,O-methyl)cellulose, Macrogol 8000, Titandioxid E 171, -30 mg zusätzl.: Eisenoxidhydrat E 172, Eisen(III)-oxid (E 172).

Remergil® 30 Child Dosage

Remergil® 6 mg/2 ml/-15 mg/5 ml Konzentrat
Zus.: 1 Amp. (2 ml/5 ml) enth.: Mirtazapin 6 mg/15 mg.
Weit. Bestandteile: Methionin, Citronensäure 1H2O, Natriumchlorid, Natriumhydroxid od. Salzsäure zur Einstellung eines pH-Wertes von 4, Wasser f. Inj.-zwecke.

Remergil® 30 Precautions, Reactions and Contraindications

Remergil® 30 Special Precautions

Remergil® 30 Special Precautions

T 60 a

Remergil® 30 Adverse Reactions

Remergil® 30 Adverse Reactions

Strenge Ind.-Stellung Gr 4 .

Related Drugs - Psychiatry/Mental Health

Back to top